Seroprevalence of hepatitis B virus infection among children and adolescents in Singapore, 2008-2010

Journal of Medical Virology

Volumn 85, Issue 4, 2013, Pages 583-588

  Ang, Li Wei ^a   Tey, Su Hui ^a   Cutter, Jeffery ^a   James, Lyn ^a   Goh, Kee Tai ^a  

^a MINISTRY OF HEALTH   (Singapore)

Author keywords

Antibody against hepatitis B surface antigen; Chronic hepatitis B virus infection; Hepatitis B surface antigen; National childhood immunization program

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; BLOOD SAMPLING; CHILD; CHILDHOOD DISEASE; CHINESE; FEMALE; HEPATITIS B; HUMAN; HUMAN TISSUE; INDIAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; PROSPECTIVE STUDY; SCHOOL CHILD; SINGAPORE; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; SINGAPORE; VACCINATION;

EID: 84873943142     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23496     Document Type: Article

References (39)

1. Chan SH, Tan KL, Goh KT, Lim C, Tsakok M, Oon CJ, Ratnam SS. 1985. Maternal-child hepatitis B virus transmission in Singapore. Int J Epidemiol 14:173-177.
2. Centre for Health Protection, Hong Kong. 2011. Hong Kong achieves goal of hepatitis B control verified by the World Health Organization Western Pacific Region. Commun Dis Watch 8:62-63.
3. Chongsrisawat V, Yoocharoen P, Theamboonlers A, Tharmaphornpilas P, Warinsathien P, Sinlaparatsamee S, Paupunwatana S, Chaiear K, Khwanjaipanich S, Poovorawan Y. 2006. Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization. Trop Med Int Health 11:1496-1502.
4. Committee on Epidemic Diseases. 1995. Seroepidemiology of hepatitis B virus infection in Singapore. Epidemiol News Bull 21:35-37.
5. Committee on Epidemic Diseases. 1996. Serological survey on hepatitis B virus infection in school children in Singapore. Epidemiol News Bull 22:57-59.
6. Committee on Epidemic Diseases. 2000. Prevalence of hepatitis B virus markers in Singapore. Epidemiol News Bull 6:1-2.
7. European Consensus Group on Hepatitis B Immunity. 2000. Are booster immunisations needed for lifelong hepatitis B immunity? Lancet 355:561-565.
8. Gay NJ, Hesketh LM, Osborne KP, Farrington CP, Morgan-Capner P, Miller E. 1999. The prevalence of hepatitis B infection in adults in England and Wales. Epidemiol Infect 122:133-138.
9. Gidding H. 2003. Australia's national serosurveillance program. NSW Public Health Bull 14:90-93.
10. Gidding HF, Warlow M, Backhouse J, Macintyre CR, Gilbert GL, McIntyre PB. 2007. The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia. Vaccine 25:8637-8641.
11. Goh KT. 1997. Prevention and control of hepatitis B virus infection in Singapore. Ann Acad Med Singapore 26:671-681.
12. Goh KT, Doraisingham S, Tan KL, Oon CJ, Ho ML, Chen AJ, Chan SH. 1989. The hepatitis B immunization programme in Singapore. Bull World Health Organ 67:65-70.
13. Goh KT, Oon CJ, Heng BH, Lim GK. 1995. Long-term immunogenicity and efficacy of a reduced dose of plama-based hepatits B vaccine in young adults. Bull World Health Organ 73:523-527.
14. Goh KT, Tan KL, Kong KH, Oon CJ, Chan SH. 1992. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore: A four year follow-up study. Bull World Health Organ 70:233-239.
15. Hennessey KA. 2011. Hepatitis B Control Western Pacific Region. Technical Advisory Group Meeting, 9 August 2011. Manila, Philippines.
16. Hong WW, Ang LW, Cutter J, James L, Chew SK, Goh KT. 2010. Changing seroprevalence of hepatitis B virus markers of adults in Singapore. Ann Acad Med Singapore 39:591-598.
17. Ioannou GN. 2011. Hepatitis B virus in the United States: infection, exposure, and immunity rates in a nationally representative survey. Ann Intern Med 154:319-328.
18. James L, Fong CW, Foong BH, Wee MK, Chow A, Shum E, Chew SK. 2001. Hepatitis B seroprevalence study 1999. Singapore Med J 42:420-424.
19. Jilg W, Schmidt M, Deinhardt F. 1988. Persistence of specific antibodies after hepatitis B vaccination. J Hepatol 6:201-207.
20. Jilg W, Schmidt M, Deinhardt F. 1989. Four-year experience with a recombinant hepatitis B vaccine. Infection 17:70-76.
21. Leuridan E, Van Damme P. 2011. Hepatitis B and the need for a booster dose. Clin Infect Dis 53:68-75.
22. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Wang F, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y. 2009. Epidemiological serosurvey of hepatitis B in China-Declining HBV prevalence due to hepatitis B vaccination. Vaccine 27:6550-6557.
23. Liew F, Ang LW, Cutter J, James L, Goh KT. 2010. Evaluation on the effectiveness of the National Childhood Immunisation Programme in Singapore, 1982-2007. Ann Acad Med Singapore 39:532-541.
24. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, Moyer LA, Bell BP, Alter MJ, Advisory Committee on Immunization Practices (ACIP). 2005. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 54:1-31. Erratum in: MMWR Morb Mortal Wkly Rep 2006; 55: 158-9, MMWR Morb Mortal Wkly Rep 2007; 56: 1267.
25. Ministry of Health, Singapore. 2011. Communicable diseases surveillance in Singapore 2010. Singapore: Ministry of Health.
26. Nelson CB. 2002. Global and regional estimates of HBV-related disease burden. In: World Health Organization Regional Office for the Western Pacific's working group meeting on viral hepatitis B. Tokyo, Japan: 26-28 June 2002 (RS/2002/GE/05).
27. O'Sullivan BG, Gidding HF, Law M, Kaldor JM, Gilbert GL, Dore GJ. 2004. Estimates of chronic hepatitis B virus infection in Australia, 2000. Aust N Z J Public Health 28:212-216.
28. Osborne K, Gay N, Hesketh L, Morgan-Capner P, Miller E. 2000. Ten years of serological surveillance in England and Wales: Methods, results, implications and action. Int J Epidemiol 29:362-368.
29. Plotkin S, Orsenstein W, Offit P. 2008. Vaccines. Philadelphia: Elsevier.
30. Robert W, Lance J, Sheryl Y, Cheryl B, David M. 2009. National serosurvey of vaccine preventable diseases. Wellington: Ministry of Health.
31. Tan KL, Goh KT, Oon CJ, Chan SH. 1994. Immunogenicity of recombinant yeast-derived hepatitis B vaccine in non-responders to perinatal immunisation. JAMA 271:859-861.
32. Wasley A, Kruszon-Moran D, Kuhnert W, Simard EP, Finelli L, McQuillan G, Bell B. 2010. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis 202:192-201.
33. WHO. 2005. Measles elimination, hepatitis B control and poliomyelitis eradication. [Regional committee meeting resolution WPR/RC56.R8]. World Health Organization, Regional Office for the Western Pacific; 23 September 2005. Available at: http://www2.wpro.who.int/rcm/en/archives/rc56/rc_resolutions/wpr_rc56_r08.htm [Accessed on 4 December 2012].
34. WHO. 2007. Western Pacific Regional Plan for Hepatitis B Control Through Immunization. World Health Organization, Regional Office for the Western Pacific; December 2007. Available at: http://www.wpro.who.int/immunization/documents/docs/POA_HepB.pdf [Accessed on 4 December 2012].
35. WHO. 2011a. First Hepatitis B Expert Panel (ERP) Consultation, Tagaytay, Philippines, 21-22 February 2011. World Health Organization, Regional Office for the Western Pacific; April 2011. Available at: http://www.wpro.who.int/immunization/documents/docs/MTGRPT_HepB1stERP.pdf [Accessed on 4 December 2012].
36. WHO. 2011b. Progress towards meeting the 2012 hepatitis B control milestone: WHO Western Pacific Region, 2011. Wkly Epidemiol Rec 86:180-188.
37. WHO Western Pacific Region. 2012a. News release, date of issue: 26 July 2012. World Hepatitis Day in the Western Pacific Region. Available at: http://www.wpro.who.int/mediacentre/releases/2012/20120726/en/index.html [Accessed on 4 November 2012].
38. WHO Western Pacific Region. 2012b. News release, date of issue: 27 September 2012. Western Pacific Region nearing 2012 milestone in hepatitis B control. Available at: http://www.wpro.who.int/mediacentre/releases/2012/20120927d/en/index.html [Accessed on 4 November 2012].
39. Wilson EB. 1927. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc 22:209-212.